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Abstract
Objective—To describe study design, patients, centers, treatments, and outcomes of a traumatic 
brain injury (TBI) practice-based evidence (PBE) study and to evaluate the generalizability of the 
findings to the US TBI inpatient rehabilitation population.
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Design—Prospective, longitudinal observational study
Setting—10 inpatient rehabilitation centers (9 US, 1 Canada)
Participants—Patients (n=2130) enrolled between October 2008 and Sept 2011, and admitted 
for inpatient rehabilitation after an index TBI injury
Interventions—Not applicable
Main Outcome Measures—Return to acute care during rehabilitation, rehabilitation length of 
stay, Functional Independence Measure (FIM) at discharge, residence at discharge, and 9 months 
post-discharge rehospitalization, FIM, participation, and subjective wellbeing.
Results—Level of admission FIM Cognitive score was found to create relatively homogeneous 
subgroups for subsequent analysis of best treatment combinations. There were significant 
differences in patient and injury characteristics, treatments, rehabilitation course, and outcomes by 
admission FIM Cognitive subgroups. TBI-PBE study patients overall were similar to US national 
TBI inpatient rehabilitation populations.
Conclusions—This TBI-PBE study succeeded in capturing naturally occurring variation within 
patients and treatments, offering opportunities to study best treatments for specific patient deficits. 
Subsequent papers in this issue report differences between patients and treatments and 
associations with outcomes in greater detail.
Keywords
brain injuries; comparative effectiveness research; rehabilitation
Traumatic brain injury (TBI) inpatient rehabilitation has been studied largely as an 
undifferentiated “black box”, with comparisons being made between patients who received 
rehabilitation and those who did not, between those who received it early versus late, or 
between those who received intensive treatment and those whose program was less 
intense.1–6 However, Chestnut et al. observed that knowing time spent without knowing 
what impairments were being treated or what methods of treatment were used may be too 
blunt an instrument to identify important sources of variance in rehabilitation outcomes.7 
This assumption is supported by results of a stroke rehabilitation comparative effectiveness 
study: average time spent in physical therapy (PT) and occupational therapy (OT) per day 
did not increase percent of variance explained in outcomes, but average time spent in 
specific PT and OT activities per day did.8
High reviewed effectiveness studies of acute rehabilitation following TBI that described (1) 
gains made during rehabilitation, (2) effects of early intervention, and (3) effects of intensity 
of rehabilitation efforts. 9 His conclusions were consistent with those of an NIH Consensus 
Conference and the Chestnut et al. evidence-based review: persons with TBI unequivocally 
make functional gains during inpatient rehabilitation–including gains in ambulation, 
independence, and cognition.7,9,10 However, it was less clear how much these gains can be 
attributed to specific rehabilitation therapies and interventions and how much should be 
attributed to age, natural recovery as modified by brain injury severity, and patient pre-
injury characteristics. Also, there was insufficient evidence to inform what the timing of 
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interventions should be, what type and intensity of interventions are most appropriate, and 
for whom specific interventions are most effective.
Inpatient TBI rehabilitation practice remains highly variable, which, in part, reflects lack of 
empirical evidence of how the complex interweaving of rehabilitation treatments from 
different professionals, in conjunction with patient prognostic factors (e.g., comorbidities, 
injury severity), influences recovery. Understanding what treatment factors and processes 
lead to better outcomes, and for which patient subgroups, would allow development of more 
effective TBI rehabilitation. However, the information required to gain this understanding is 
very complex and requires capturing detailed information regarding injury type and severity, 
the types, timing, and amounts of interventions received, and how these factors affect 
outcomes across diverse types of patients. A necessary first step in deciphering the content 
of the “black box” is to develop a comprehensive index of patient prognostic factors that 
allows for standardized assessment of patient differences in illness and injury severity 
following TBI. Second, a standard taxonomy of TBI inpatient rehabilitation treatments for 
each discipline would allow researchers to capture reliably the targets of treatments, the 
types, intensities, and durations of rehabilitation activities performed, as well as other 
treatment process factors. We can then identify variance in outcomes, along with those 
patient and treatment factors that are associated with that variance. The evidence gleaned 
may be used to inform delivery of future treatment by patient characteristics, design of 
randomized controlled trials, guide clinical pathways development, or stimulate 
development of new and innovative treatment approaches.
It is likely that an interaction of interventions and patient factors influences outcomes–that 
is, what is optimal treatment for one patient subgroup may have no or very limited impact on 
another group with different needs or abilities to benefit. In rehabilitation, multiple 
interventions are provided daily by professionals from varied disciplines, backgrounds, and 
experiences, and nested within rehabilitation facilities with varied customs, cultures, and 
physical environments. Relatively small effects of a single intervention may be magnified 
when used in combination with other interventions.11 Interventions that seem effective when 
studied in isolation may be antagonistic when provided together. In current TBI 
rehabilitation practice, the large variation in treatments delivered and outcomes produced, 
between as well as within facilities, affords an opportunity to compare the relative 
effectiveness of combinations and intensities of interventions among patients with TBI.
Practice-Based Evidence (PBE) study methodology provides an efficient, comprehensive 
means of implementing comparative effectiveness research.11 The 5-year TBI rehabilitation 
project described in this paper and in other articles in this supplement used PBE research 
methodology to isolate specific components of rehabilitation treatments, as has been done in 
previous PBE rehabilitation inpatient treatment studies.8,12–14 The specific aims of the TBI-
PBE project were to: (1) identify individual patient characteristics, including demographic 
data, severity of brain injury, and severity of illness (complications and comorbidities), that 
may be associated with significant variation in treatments selected and in outcomes of acute 
rehabilitation for TBI, (2) identify medical procedures and therapy interventions, alone or in 
combination, that are associated with better outcomes, controlling for patient characteristics, 
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and (3) determine whether specific treatment interactions with age, severity/impairment, or 
time are associated with better outcomes.
In this introductory paper, we first provide an overview of the study design, centers, and 
methods. Second, we briefly describe the primary measures and variables used to describe 
patients who sustained TBI, with an emphasis on stratification by admission Functional 
Independence Measure (FIM) Cognitive Scale Score groupings, and the results in our 
sample. Third, we provide an overview of the point of care forms (POC) incorporating our 
treatment taxonomy used to capture information on treatments and the most common 
treatments used by each discipline. Fourth, we describe inpatient rehabilitation outcomes for 
our sample. Lastly, for the purposes of evaluating generalizability, we compare the project’s 
US subsample to the US rehabilitation population of persons with TBI.
METHODS
Study Design
The TBI-PBE project was led by the first and second author, with local Co-investigators in 
the 10 participating centers listed in table 1. The process used was as follows:
1. A multi-center, trans-disciplinary Clinical Project Team was established that was 
comprised of Co-Investigators (medical director or lead researcher) and leads from 
each discipline (Rehabilitation Medicine, Nursing, PT, OT, Speech Language 
Pathology (SLP), Therapeutic Recreation, Social Work, and Neuropsychology) at 9 
TBI rehabilitation centers in the US and 1 in Canada. Persons who had sustained a 
TBI several years prior and family members of persons with TBI were also part of 
this team. The Clinical Project Team (a) identified and defined all study variables 
including outcomes of interest, (b) proposed hypotheses for testing, (c) provided 
leadership and guidance through all phases of data collection and analysis, and (d) 
contributed to reporting and drawing conclusions. They fostered trans-disciplinary 
communication and training across traditional scientific and clinical boundaries.
2. Front-line clinicians developed a TBI Auxiliary Data Module (ADM) to capture 
detailed patient, process, and outcome data that are found in the patient’s medical 
record. Many ADM variables had date and time fields so that they could be 
associated with other variables in time sequence. Examples of variables included in 
the ADM are demographic data, past medical history, injuries, injury severity, 
medical comorbidities and complications, rehabilitation interruptions, laboratory 
findings, vital signs, weight, height, use of restraints, weight bearing restrictions, 
presence of tracheostomy and gastrostomy tubes, and tube feeding information. 
Longitudinal data on rehabilitation progress and barriers were collected, including 
routinely measured functional independence, agitation, sleep, pain, and level of 
treatment engagement. To take into account each patient’s comorbidities and 
severity of illness, we used the Comprehensive Severity Index (CSI®) as the 
primary severity adjustment measure.15–21
3. Data abstractors at each center were trained to collect ADM data using a web-based 
software system. These staff attended a 4-day training that included both didactic 
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and practice sessions. After training, we used weekly conference calls of all 
abstracters to address such issues as how to handle certain chart wording. Chart 
review occurred after patient discharge and took approximately 4 hours per subject. 
Reliability monitoring was conducted for abstracters after their first 4 charts were 
completed and again after 25 charts. Subsequently, reliability testing occurred 
periodically throughout the years when data were being collected. Charts were 
selected randomly from completed cases and re-abstracted by a reliability team 
member. A 95% agreement rate between the abstracter and reliability staff was 
required for each reliability test. Re-training was performed as needed if the data 
abstractor did not attain 95% agreement.
4. Using weekly conference calls, lead therapists of various disciplines from 
participating centers engaged in an iterative process to (a) identify and define 
individual components of each discipline’s care process, (b) create discipline-
specific documentation tools to document care processes not detailed in the medical 
record in order to quantify the delivery of those components (called POC 
documentation tools used for each therapy session), and (c) incorporate POC 
documentation into routine facility practices (See Appendix 1 containing POC 
tools). Clinicians created the POC tools based on their theoretical understanding, 
research evidence to date, existing guidelines, and their clinical experience. POC 
forms allowed recording of time spent on specific functional activities (e.g., sitting, 
transfers, sit-to-stand, pre-gait, gait, advanced gait, community mobility, etc. in 
PT).22
5. The Lead Therapist in each participating discipline at each center underwent 
extensive training using POC training materials established by the project team. 
Train-the-trainer sessions were held for Lead Therapists who conducted subsequent 
discipline-specific training programs for their colleagues to teach them how to use 
the POC documentation. In total, over 950 therapists were trained. During the 30 
months of data collection, weekly discipline-specific conference calls of the Lead 
Therapists were held to address questions concerning documentation and ensure 
consistent POC data completion across centers. To check reliability, periodically 
clinicians were given case scenarios and asked to complete POC documentation 
based on the scenarios. Agreement with the answer key was measured and 
aggregated results for each discipline in each center were reported back to the 
center. Clinician-specific problems were identified, and if necessary, additional 
training was held if agreement was <90%. Each therapy session was documented 
by the treating therapist after the patient encounter. Group therapy was recorded 
and included documentation of the number of patients, therapists, and assistants 
involved in the group. Nurses documented pain, sleep, and agitation during each 
shift. Hardcopy POC information was entered into a web-based data collection 
system by research assistants.
6. Medication administration data were downloaded from center electronic medical 
record systems into the centralized research database.
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7. Staff from each center was trained on how to track patients for follow-up after 
leaving inpatient care, as well as how to conduct follow-up interviews. Protocols 
used by the TBI Model Systems for tracking and interviewing were adapted for the 
study;23 training was conducted by experienced TBI Model Systems researchers. 
The TBI Model Systems protocol for interviewing the “best source” of information
—patient or proxy—was used in this study. Follow-up phone interviews with 
patients or their proxies were conducted at 3 and 9 months post-discharge, using a 
+/− 1-month window.
8. Short surveys (provider profiles) were used to collect information on clinician 
training and experience at each site. In addition, local investigators completed a 
facility survey with questions about structures and processes in the brain injury 
rehabilitation unit (See TBI-PBE study facility descriptions in this issue).24
9. Using site and patient ID the data center merged these data from multiple sources 
to create a patient-level database with all the data elements over the course of each 
patient’s rehabilitation stay and follow-up interviews.
10. Data were checked for completeness and accuracy (e.g., sensible value entries such 
as dates within the study time period and sequential timing of linked process steps 
or unrealistic values and obvious outliers). Data were cleaned before analysis was 
started.
Study Sample
Ten participating rehabilitation centers enrolled all consenting eligible patients admitted to 
their specialty brain injury unit, resulting in a consecutive sample of adolescents and adults 
with TBI receiving inpatient rehabilitation between October 2008 and September 2011 
(overall 82.5% of patients consented). We chose to include sites in the US as well as Canada 
in order to study a broad range of patient characteristics and treatment practices. The 
Institutional Review Board at each study center approved the study; each patient or his/her 
proxy gave informed consent.
The final study sample was 2130 patients (586 females and 1544 males; 113 between age 14 
and 18) treated over 2.5 years. Inclusion criteria were:
1. Age over 14 years
2. Sustained a TBI, defined as damage to brain tissue caused by external force and 
evidenced by loss of consciousness, post-traumatic amnesia (PTA), skull fracture, 
or objective neurological findings
3. TBI was characterized with an International Classification of Diseases (ICD-9-CM) 
code consistent with the Centers for Disease Control and Prevention Guidelines for 
Surveillance of Central Nervous System Injury:1
800.0–801.9 – Fracture of the vault or base of the skull
803.0–804.9 – Other and unqualified multiple fractures of the skull
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850.0–854.1 – Intracranial injury, including concussion, contusion, laceration, 
and hemorrhage
873.0–873.9 – Other open wound to the head
905.0 – Late effects of fracture of the skull and face
907.0 – Late effects of intracranial injury without mention of skull fracture
959.01 – Head injury, unspecified
4. Received their first, complete inpatient care on the designated adult brain injury 
rehabilitation unit
Functional severity—The FIM, used as a measure of the severity of functional deficits 
upon entry into treatment, consists of 18 items in two domains: Motor (13 items) and 
Cognitive-communicative (5 items). Each item is rated on a 7-category scale, ranging from 
1: total assistance, to 7: complete independence. To eliminate distortion in quantifying the 
status of patients whose capability is at the extremes of the instrument’s range, the Motor 
and Cognitive subscores were recoded separately using tables published by Heinemann et al. 
that were based on Rasch analysis of data of a large brain injury sample.25
Comorbidity—CSI, developed over a period of 30 years, defines severity as the 
physiologic and psychological complexity presented to medical personnel due to the extent 
and interactions of a patient’s injury(s) and disease(s). CSI is age- and disease-specific, and 
is independent of treatments. It provides an objective, consistent method to operationalize 
patient severity of illness based on over 2,100 individual signs, symptoms, and physical 
findings and over 5,600 disease-specific criteria sets related to all of a patient’s injury(s) and 
disease(s), not just on diagnostic information (ICD-9-CM coding) included in a discharge 
summary. CSI has been validated extensively in inpatient, ambulatory, rehabilitation, and 
long-term care studies since 1982.15–21
The CSI modification used in the present study allowed separation of severity of brain injury 
from severity of illness resulting from all other injuries, complications, and comorbidities. 
This use of CSI allowed detection of patient brain dysfunction differences that might 
otherwise be hidden or “washed out” by the effect of an overall injury severity score. Some 
criteria included in the brain CSI component were amount of intracranial bleeding, length of 
PTA, Glasgow Coma Scale (GCS), amount of compression, hydrocephalus, pupil reaction, 
etc.
CSI scores were calculated for three time spans of the patient’s stay in rehabilitation:
• Admission CSI is based on all information available for the first 72 hours of the 
rehabilitation stay. It assesses how sick the patient was on admission to the 
rehabilitation facility.
• Discharge CSI reflects information from the last 72 hours before discharge.
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• Maximum CSI uses information from the entire stay, including the admission and 
discharge periods. It measures the most aberrant findings, regardless of when they 
occurred.
Patient Variables—Variables describing patient characteristics, including demographics 
and injury characteristics, are included in table 2 overall and by admission FIM Cognitive 
subgroup.
Process Variables—As described above, we collected process variables in two ways: 
from therapy intervention POC forms and from chart review (ADM). Table 3 provides a 
selection of relevant findings. It also includes clinician experience calculated for the 
“average” clinician within a discipline who saw the patient as follows: Clinician experience 
index = ((sum of minutes by clinician #1 * years experience of clinician #1) + (sum of 
minutes by clinician #2 * years experience of clinician #2) + (etc))/(total minutes with 
included clinicians).
Rehabilitation Course Variables—Besides the patient data available on admission, we 
collected additional variables that describe the patients during the course of their 
rehabilitation unit stay using the ADM. These include descriptions of aphasia, dysphagia, 
ataxia, PTA (based on neuropsychologists’ ratings on one of two analogous standardized 
assessments, i.e., the Orientation Log and the Galveston Orientation and Amnesia Test), 
pain, agitation, sleep, and falls. Table 4 provides information on these data elements.
Outcome Variables—Three main outcome variables at discharge were: discharge FIM, 
length of stay (LOS) (which excludes days out of the rehabilitation facility for readmission 
to acute care), and discharge destination. We also examined readmission to acute care during 
rehabilitation as an outcome. In addition, outcomes collected post-discharge via telephone 
interview included hospitalizations post-discharge, employment, education, FIM, 
community participation (measured by the Participation Assessment with Recombined Tools 
Objective- PART-O, a 17-item objective tool representing functioning at the societal 
level),26 and subjective well-being (measured by Satisfaction with Life Scale- SWLS, a 5-
item instrument used to measure life satisfaction).27 The summary score for the PART-O 
represents the average of item scores ranging from 0 to 5, while the SWLS Total score is a 
sum of the 5 items, ranging from 7–35. For both measures, higher scores represent better 
functioning or satisfaction. A summary of these data elements is provided in tables 5 and 6.
Data Analyses
Analyses were performed using SAS version 9.2 (SAS Institute, Inc., Cary, NC). When data 
were missing, one or more adjustments were made depending on the variable and its 
intended use in analyses. Sometimes we categorized values simply as “unknown” (and 
included the category in analysis as a dummy variable representing missingness); sometimes 
we excluded patients with missing data from analysis; and sometimes we collapsed 
continuous variables with missing data into categorical variables and placed the cases with 
missing information into a category using corroborating data available. For example, we did 
not always have a patient’s Body Mass Index, but had other weight- and height-related 
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information (e.g., an order for a bariatric wheelchair) that allowed categorizing a patient 
broadly, e.g., as overweight or obese.
Since we knew that our sample had patients with a wide range of functional disability, in the 
analysis our first step was to determine homogeneous subgroups of patients with TBI 
severity of brain injury. We tried different ways to create homogeneous subgroups and 
compared these ways based on how much variation in the outcomes was explained (R2 and c 
statistics) and how distinct the subgroups were. After exploring many possible approaches, 
including Case Mix Groups as defined for inpatient rehabilitation patients with TBI,28 time 
to clear PTA, and various combinations of admission FIM motor and cognitive scores, we 
determined that the admission FIM cognitive score was the best way to form relatively 
homogenous subgroups of TBI patients and defined five subgroups (score ≤6, 7–10, 11–15, 
16–20, ≥21).
We used frequencies and percentages for categorical patient, treatment, rehabilitation 
course, and outcome measures, and means, medians, and amount of variation (SD and 
range) to summarize continuous measures. We conducted bivariate analyses to examine how 
different the patients were across the 5 FIM cognitive subgroups. For categorical variables, 
we created contingency tables and used chi-squared tests to determine significance of 
bivariate associations. For continuous variables we used analysis of variance. A two-sided p 
value <0.05 was considered statistically significant.
In order to examine how the TBI-PBE study patients compare to patients with TBI who 
received inpatient rehabilitation in the US during specific years, we used two sources of data 
regarding the total US TBI inpatient rehabilitation population (i.e., 99,438 for 2001–2007, 
and 156,447 for 2001–2010). Two papers provided most variables of interest (e.g. age 
group, LOS category, etc.) in percentages, which were converted to raw numbers by 
multiplying each with their respective US TBI population totals.29,30 The 2001–2007 values 
were subtracted from the 2001–2010 values to get the 2008–2010 values. These raw 
numbers were then converted back into percentages using 156,447 − 99,438 = 57,009 as the 
denominator (our estimate for the US TBI population between 2008 and 2010). As done 
with previous comparisons to national data, differences less than 5% were considered 
immaterial; those ≥ 5% but < 10% were considered minor; and those ≥ 10% were 
considered important.26 Only US TBI-PBE patients were included in the comparison.
RESULTS
The average age of the 2130 patients was 44.5 (SD=21.3), with 72.5% male and 74.4% 
white non-Hispanic, 15.1% black, 6.2% white Hispanic, and 4.4% in the Miscellaneous 
race/ethnicity group. In table 2 we show the patient pre-injury and injury characteristics 
overall and within each admission cognitive subgroup. The less impaired cognitive 
subgroups (score ≥16) generally were older and contained more retired people; had a greater 
percentage females; were better educated; had Medicare more often as payer and Medicaid 
less often; and were heavier (higher BMI). These groups had a lower percentage of patients 
with paralysis or diabetes; a lower admission CSI; and a higher percentage with injury due 
to falling with more mild impairment (GCS 13–15) immediately after injury. Higher 
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cognitive subgroups also had the following: less frequently midline shift present; fewer 
subarachnoid or intraventricular hemorrhages; fewer craniectomies performed; and less time 
from injury to rehabilitation admission. These patients also had less functional impairment 
as measured by FIM motor score.
The admission FIM cognitive subgroups had different percentages of patients receiving 
various medications, nutritional supports, and other treatments. The lowest admission 
cognitive subgroups (score ≤ 10) had a greater percentage of patients being physically 
restrained and getting one-on-one observers during rehabilitation; more often had enteral 
and parental nutrition; more often had a tracheotomy; and received more psychoactive and 
other medication use.
The lower cognitive functioning subgroups also differed in percentage of patients receiving 
various therapy activities, as well as in amount of treatment (cumulatively over their stay) by 
each discipline for those patients receiving each activity. Treatment time differences were 
closely associated with LOS differences. Examples of these data are presented in table 3. 
The low functioning groups had fewer minutes/week of PT therapeutic exercise and more 
minutes/week gait training and standing. In OT, these subgroups had fewer minutes/week in 
upper extremity activity and lower body dressing and more minutes/week in cognitive 
activity. For SLP, lower functioning cognitive patients had fewer minutes/week of education 
and verbal reasoning, along with more minutes/week of verbal orientation review. In 
psychology, in general the highest percent of patients receiving each activity and for more 
minutes/week was the middle functioning cognitive subgroup (score 11–15); subgroups 
functioning at a lower level on admission tended to receive fewer minutes/week of 
psychology activities. Recreational therapy also tended to be given more frequently to 
patients in the middle cognitive functioning subgroup, but more minutes/week of most 
activities were given to patients in the higher functioning admission cognitive subgroups. A 
higher percent of patients in the lowest admission cognitive subgroup received social work/
case management activities.
Whereas table 2 provides patient pre-injury and injury characteristics, table 4 offers 
information on events and experiences during the rehabilitation stay. As expected, patients 
in the lower admission cognitive functioning subgroups had moderate to severe aphasia, 
dysphagia, and ataxia more often, longer time in PTA, and a greater percentage of their stay 
characterized by an agitated state.
Outcomes at discharge and at approximately 3- and 9-months post-discharge (approximately 
1-year post-injury for most) are presented in tables 5 and 6, respectively. Table 7 provides 
key information on the original sample of 2130 (last column), and the samples that we 
classified as having a 3-month post-discharge and a 9-month post discharge follow-up 
interview, as well as for ANY follow-up. For the 3-month interviews, the average time from 
discharge to the interview was 98.5 days (SD=28.0. range 56 – 189 days); for the 9-month 
interviews, the average time from discharge to the interview was 309.3 days (SD=43.3. 
range 208 – 402 days). In Table 7 we also included a description of patients who had a 1-
year post-injury interview. Because the 1-year post-injury anniversary date could fall in the 
window for any post-discharge interview, depending on the patient’s length of stay in acute 
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and rehabilitation settings, additional questions required for the 1-year post-injury interview 
for TBI Model Systems database participants were included in the follow-up interview that 
fell within the window for 3- or 9-month post-discharge interview. The outcomes generally 
show an association with the severity of the cognitive impairment at admission, with less 
impaired patients showing shorter LOS, more discharges to home, higher levels of 
functioning (FIM) at discharge, 3, and 9 months, fewer post-discharge hospitalizations, and 
fewer deaths post discharge.
In table 8 we compare the TBI-PBE US study patients to the US inpatient rehabilitation 
population. With such large numbers for the US TBI patients, all differences are statistically 
significant (p<.001). The TBI-PBE patients tend to be younger, and hence are less often 
covered by Medicare and more often by Medicaid and private payers. TBI-PBE patients are 
more severely injured, with a higher percentage with an admission motor FIM ≤ 23 and 
admission cognitive FIM ≤ 15; there also is a greater percentage of patients in the most 
severe TBI Case Mix Group (207) and with a rehabilitation LOS of over 20 days. However, 
after we separated the TBI-PBE sample by age at < and ≥ 65 years, the vast majority of 
differences became immaterial or minor (<10%).
DISCUSSION
There is a significant need for evidence in TBI rehabilitation that delineates the extent that 
differences in outcomes are attributable to patients’ characteristics such as age, severity, 
time since injury, and pre-injury factors, and how much outcomes can be attributed to the 
timing and dose of specific rehabilitation interventions. Our large sample, 10-center, 
comparative effectiveness study using the PBE methodology provides information on a 
comprehensive set of patient prognostic factors; information on the types, intensity, and 
duration of key activities used in interdisciplinary rehabilitation using a separate taxonomy 
for each discipline; and outcomes at inpatient rehabilitation discharge and 3 and 9 months 
later.
Our sample of 2,130 was diverse with regard to demographics, injury (etiology, physiologic 
damage, and severity), and functioning (FIM Cognitive and Motor scores) at inpatient 
rehabilitation admission. Sample stratification into 5 levels of functional capacity based on 
admission FIM Cognitive scores resulted in sufficiently large subsamples (N range 339 to 
504) for between group analyses. Strong evidence of differentiation between the 5 cognitive 
groups was observed with regard to acute brain injury severity (GCS scores), brain damage 
(midline shift and subarachnoid hemorrhage), nature of the acute care received 
(craniectomy, tracheotomy or ventilation, and length of stay), inpatient rehabilitation 
admission brain injury severity (CSI Brain Injury scores and presence of severe dysphagia, 
aphasia, and ataxia), and inpatient rehabilitation admission motor functioning.
Our POC forms developed as part of this study allowed clinicians to document a wide range 
of therapeutic activities potentially used within each discipline including PT (19 separate 
activities), OT (36), SLP (86), TR (43), PSY (8), and Social Work (6). ). In each discipline, 
significant heterogeneity in treatment activities delivered was observed within and between 
groups. For example, gait training was the most frequently delivered PT activity (about 80 
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minutes per week) across all subgroups but the consistently large SDs indicate that the 
average minutes per week of gait training ranged from 0 minutes to well over 3 hours within 
each group (table 3). Within and across subgroups, there is variation in whether or not 
patients get a particular treatment (%), and the average minutes they get per week. Across 
disciplines, persons in the highest functioning cognitive group participated in the most 
minutes of formal assessment/testing per week, likely reflecting a combination of short stays 
and greater ability to complete test requirements, resulting in less overall time in other 
activities.
Inpatient rehabilitation outcomes showed trends in the expected direction across the 5 
admission cognitive categories. Patients admitted with more severe cognitive impairments 
had lower inpatient rehabilitation discharge cognitive and motor functional outcomes, higher 
inpatient rehabilitation discharge brain injury CSI scores, longer inpatient rehabilitation stay, 
and were more likely to be discharged to an institutional setting. Nine-month post discharge 
outcome data suggest that all patient subgroups had improved cognitive and motor 
functioning (table 6).
The quality of evidence to be derived from our prospective, multi-center, longitudinal study 
rests on standardized data collection tools, completeness of data collection, and very low 
attrition rates after inpatient rehabilitation discharge. The follow-up rate (79%) for one-year 
post-injury outcomes approached the benchmark of 80% for follow-up completeness. 
Examination of interactions and potential confounds as alternative explanations for the 
differences in outcomes between the 5 admission cognitive subgroups as well as evaluation 
of the effects of treatments on outcomes was beyond the scope of this introductory paper. 
Future analyses, including studies published in this supplement, will explore confounds 
when evaluating: (1) what percent of variation in treatment is accounted for by variation in 
patient characteristics, (2) what percent of variation in outcomes is accounted for by 
variation in treatment after controlling for patient and injury characteristics, and (3) what 
treatments and treatment patterns are most strongly related to positive outcomes for specific 
subgroups of patients.
Evidence from this study has important implications for future research as well as for the 
way that injury is categorized for persons with TBI receiving inpatient rehabilitation. The 
demographic, injury severity, and functional diversity of this large, multi-center sample 
along with the heterogeneity of both treatments delivered and outcomes observed within 
each of the cognitive subgroups increases the likelihood that statistical modeling will 
identify treatments that are associated with outcomes of interest. Preliminary evidence 
suggests that categorization of patients with TBI based on functional cognition at inpatient 
rehabilitation admission produces associations with injury characteristics, inpatient 
rehabilitation admission level of motor functioning and secondary conditions, rehabilitation 
discharge outcomes, and one-year post-injury outcomes. Historically, case-mix stratification 
in rehabilitation, e.g., Case Mix Groups 201–207, has focused on the physical dimension of 
functioning, differentiating 7 levels of FIM motor functioning within TBI admissions. 
Cognitive functioning (dichotomized as FIM Cognitive scores < or ≥23.5 is used only to 
differentiate among patients with a (weighted) Motor score of more than 44.25. Yet, our 
preliminary data show that cognition- and behavior-focused activities are common if not 
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predominant in SLP, OT, and psychology interventions and that the current Case Mix 
Groups may undervalue the cognitive dimension. Our preliminary analysis indicates that 
additional levels of stratification by cognitive functioning in the TBI rehabilitation 
population yield important prognostic information. Further evidence that patients in specific 
cognitive subgroups substantially benefit from additional rehabilitation treatment not 
factored into current case-mix groups may argue for case-mix reform with more emphasis 
placed on the cognitive dimension in inpatient rehabilitation treatment.
Findings from the TBI-PBE study are likely to generalize to the US rehabilitation population 
of persons with TBI. A comparison of our sample to a concurrent group of U.S. patients, 
when dichotomized at age 65, indicated that persons in our sample were similar to persons 
in their respective age groups in the wider US TBI rehabilitation population.
CONCLUSIONS
This prospective, 10-center, comparative effectiveness study using the PBE methodology 
succeeded in developing a standardized treatment taxonomy and prospectively capturing 
naturally occurring variation within patients and treatments. This preliminary information 
offers a basis for subsequent papers from this study to investigate best treatments for 
specific patient impairments and groups.
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Appendix 1
TBI-PBE Physical Therapy Form v.3.19.09
TBI-PBE Occupational Therapy Form v.11.19.08
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TBI-PBE Speech and Language Pathology Form v. 1.15.09
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TBI-PBE Therapeutic Recreation Form v.10.6.08
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TBI-PBE Psychology Form v.10.6.08
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TBI-PBE Agitated Behavior Scale (ABS) - Nursing POC v.10.1.08
TBI-PBE Nursing Form v.10.1.08
TBI-PBE SW/CM ADMISSION FORM v.10.6.08
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TBI-PBE SW/CM DISCHARGE FORM v.10.6.08
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TBI-PBE Social Work/Case Management Form v.10.6.08
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Table 1
Participating Rehabilitation Centers
Facility Location
Wexner Medical Center* Columbus, OH
Carolinas Rehabilitation, Carolinas HealthCare System* Charlotte, NC
Mount Sinai Medical Center* New York, NY
National Rehabilitation Hospital Washington, DC
Shepherd Center Atlanta, GA
Intermountain Medical Center Salt Lake City, UT
Rush University Medical Center Chicago, IL
Brooks Rehabilitation Hospital Jacksonville, FL
Loma Linda University Rehabilitation Institute Loma Linda, CA
Toronto Rehabilitation Institute Toronto, Ontario
*
TBI Model System center
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